| Document Date: 2014-06-03 16:13:40
Open Document File Size: 1,86 MBShare Result on Facebook
Country United States / / Currency USD / / IndustryTerm insurance coverage / treatment for end-stage lung diseases / lung repair technologies / treatment for endstage lung diseases / / MedicalCondition restrictive lung disease / bronchopulmonary dysplasia / obstructive lung disease / endstage lung diseases / immunodeficiency disorders / pneumonia / CMV viremia / hypertension / chronic rejection / cardiovascular/cerebrovascular disease / pulmonary diagnoses / disease / respiratory failure / advanced lung disease / idiopathic pulmonary fibrosis / chronic obstructive pulmonary disease / B deficiency / diabetes / pulmonary vascular disease / pulmonary hypertension / chronic obstructive lung disease/emphysema / Posttransplant lymphoproliferative disorder / pulmonary fibrosis / EBV infection / bronchiolitis / acute respiratory distress / lung disease / diseases / graft dysfunction / pulmonary embolism / infection / cystic fibrosis / renal dysfunction / infections / reported diabetes / bronchiolitis obliterans / idiopathic pulmonary arterial hypertension / syndrome / End-stage lung diseases / antitrypsin deficiency / drug-treated hyperlipidemia / / MedicalTreatment heart-lung transplant / IMMUNOSUPPRESSION / kidney transplant / Lung transplants / organ transplant / organ transplants / extracorporeal membrane oxygenation / liver-lung transplant / lung transplant / / Organization OPTN Board of Directors / Medicare / / Person Patient / / / Product cyclosporine / azathioprine / / ProvinceOrState Kansas / Alaska / District of Columbia / Maryland / Delaware / / Technology alpha / lung repair technologies / antibodies / transplantation / /
SocialTag |
lung 139 wait list 146 deceased donation 149